Clark Capital Management Group, Inc.

Source: SEC Form 13F · as of Mar 2026

Clark Capital Management Group, Inc. holds 30 biotech & pharma companies tracked by BioSniper, totaling $1.13B in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$1.13B

CompanySharesValue
JNJJOHNSON & JOHNSON935,339$228.6M
LLYELI LILLY & Co142,217$130.8M
AZNASTRAZENECA PLC600,052$118.3M
ABBVAbbVie Inc.474,417$103.2M
RPRXRoyalty Pharma plc1,639,968$78.7M
MRKMerck & Co., Inc.640,272$77.0M
CORCencora Inc.211,212$66.4M
PMPhilip Morris International Inc357,523$59.1M
MCKMcKesson Corporation62,812$54.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)182,425$49.4M
DGXQuest Diagnostics Incorporated235,422$46.1M
NVSNovartis AG251,894$38.5M
LGNDLigand Pharmaceuticals Incorporated90,206$18.0M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.86,509$14.9M
CPRXCATALYST PHARMACEUTICALS, INC.568,676$14.1M
HALOHALOZYME THERAPEUTICS, INC.214,102$13.8M
GMEDGlobus Medical Inc.100,687$8.7M
CAHCardinal Health Inc.33,750$7.1M
UTHRUNITED THERAPEUTICS Corp3,234$1.9M
MEDPMedpace Holdings Inc.2,880$1.4M
ABTABBOTT LABORATORIES7,679$788K
PFEPFIZER INC23,157$650K
AMGNAMGEN INC1,449$510K
SUNSUNSET ISLAND GROUP5,500$357K
ZTSZoetis Inc.2,703$320K
GMOptec International, Inc.3,250$242K
ELVElevance Health Inc.806$236K
GILDGILEAD SCIENCES, INC.1,674$233K
IDXXIDEXX LABORATORIES INC /DE405$228K
VRTXVERTEX PHARMACEUTICALS INC / MA487$217K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Clark Capital Management Group, Inc. — Biotech 13F Holdings & Portfolio | BioSniper